As of 2025-09-18, the Relative Valuation of Inhibrx Inc (INBX) is 531.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.53 USD, the upside of Inhibrx Inc based on Relative Valuation is 1904.3%.
The range of the Relative Valuation is (106.18) - 1,208.12 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.6x | 13.2x |
| Forward P/E multiples | 12.8x - 13.5x | 13.2x |
| Fair Price | (106.18) - 1,208.12 | 531.83 |
| Upside | -500.1% - 4452.9% | 1904.3% |
| Date | P/E |
| 2025-09-17 | -3.19 |
| 2025-09-16 | -3.20 |
| 2025-09-15 | -3.27 |
| 2025-09-12 | -3.31 |
| 2025-09-11 | -3.42 |
| 2025-09-10 | -3.33 |
| 2025-09-09 | -3.56 |
| 2025-09-08 | -3.50 |
| 2025-09-05 | -3.39 |
| 2025-09-04 | -3.34 |
| 2025-09-03 | -3.35 |
| 2025-09-02 | -3.32 |
| 2025-08-29 | -3.39 |
| 2025-08-28 | -3.36 |
| 2025-08-27 | -3.30 |
| 2025-08-26 | -3.12 |
| 2025-08-25 | -3.01 |
| 2025-08-22 | -3.01 |
| 2025-08-21 | -2.91 |
| 2025-08-20 | -2.94 |
| 2025-08-19 | -2.77 |
| 2025-08-18 | -2.87 |
| 2025-08-15 | -2.81 |
| 2025-08-14 | -2.88 |
| 2025-08-13 | -2.84 |
| 2025-08-12 | -2.64 |
| 2025-08-11 | -2.58 |
| 2025-08-08 | -2.53 |
| 2025-08-07 | -2.57 |
| 2025-08-06 | -2.53 |
| 2025-08-05 | -2.52 |
| 2025-08-04 | -2.62 |
| 2025-08-01 | -2.60 |
| 2025-07-31 | -2.64 |
| 2025-07-30 | -2.77 |
| 2025-07-29 | -2.92 |
| 2025-07-28 | -2.96 |
| 2025-07-25 | -2.78 |
| 2025-07-24 | -2.78 |
| 2025-07-23 | -2.79 |
| 2025-07-22 | -2.75 |
| 2025-07-21 | -2.66 |
| 2025-07-18 | -2.94 |
| 2025-07-17 | -2.84 |
| 2025-07-16 | -2.85 |
| 2025-07-15 | -2.76 |
| 2025-07-14 | -2.76 |
| 2025-07-11 | -2.62 |
| 2025-07-10 | -2.53 |
| 2025-07-09 | -2.52 |